What's new

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised

Feb 27, 2025 - 10:44
 0
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 38, Status: Authorised
Read More

Tags:

Previous Article

Kia EV4, PV5 and Concept EV2 make debuts at 2025 Kia EV Day as embodiment of exp...

Next Article

LVMH spotlights staff in new campaign

Related Posts

Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Webinar on PMS Project Made Easy: Summary of activities and Practical Tips for SMEs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 February 2025, 14:00 (CET) to 24 February 2025, 16:00 (CET)

Webinar on PMS Project Made Easy: Summary of activities...

Feb 11, 2025  0

Herbal medicinal product: Centaurii herbaArray, C: ongoing call for scientific data

Herbal medicinal product: Centaurii herbaArray, C: ongo...

Feb 14, 2025  0